Wegovy can be taken with or without food, as its absorption is unaffected by meals. Some people prefer to inject after a light meal or...

Yes, Wegovy and metformin are often used together in people with type 2 diabetes, and no special dose adjustment is typically required....

In major STEP trials, Wegovy led to about 15% weight loss over 68 weeks. Contrave (called Mysimba in the UK) generally achieves around...

Wegovy contains semaglutide at a higher dose and is licensed for weight management, while Trulicity (dulaglutide) is prescribed for type...

Wegovy has been tested in large clinical trials and shown to deliver sustained, clinically meaningful weight loss. Over-the-counter...

Yes, trial evidence shows that Wegovy works best when combined with healthy eating and physical activity, leading to average weight...

Many people on Wegovy report fewer food cravings and better control over eating, which can reduce stress around meals. Other drugs like...

Clinical trials included adults up to their mid-70s, and weight loss benefits were seen across age groups. There’s limited evidence...

Wegovy is made as a biologic medicine, meaning it uses recombinant technology to produce semaglutide, a protein-based drug. Mysimba and...

Both contain semaglutide and improve blood sugar by enhancing insulin release and reducing glucagon. Ozempic is specifically licensed for...

Yes — trials show Wegovy users lose more weight earlier than with Saxenda, thanks to its stronger appetite effect and weekly dosing. That...

In many cases, Wegovy can be used as the main weight loss medicine, especially when diet and exercise alone haven’t worked. However,...

Both Wegovy (semaglutide 2.4 mg) and Trulicity (dulaglutide) improve blood sugar, but semaglutide generally produces greater reductions...

The most common side effects with Wegovy are gastrointestinal, such as nausea and diarrhoea, and these often lessen over time. Other...

Yes, Wegovy has strong evidence in people with type 2 diabetes, cardiovascular disease, and sleep apnoea, where weight loss can improve...

No, even though both contain semaglutide, they are licensed for different uses and come in different devices and doses. Doctors may...

The SELECT trial showed semaglutide 2.4 mg (Wegovy) reduced the risk of major heart problems in people with overweight or obesity and...

In the UK, coverage depends on NHS commissioning rather than insurance, and NICE now recommends Wegovy within specialist services....

Wegovy works directly on appetite signals in the brain, helping people feel full sooner and think less about food. Other medicines act...

Wegovy has shown sustained weight loss of around 15% at 68 weeks, and many participants maintained benefits at two years. Qsymia (not...